FDA Says CBD Still Can’t Be Dietary Supplement

January 26, 2023 · Green Market Report

The agency called on Congress to develop a better regulatory framework for CBD

The U.S. Food and Drug Administration this week announced that it would deny a trio of petitions that requested authorization for cannabidiol (CBD) to be used as a dietary supplement. The agency also advised that Congress needs to establish a better regulatory framework before such a classification is allowed.

Based on existing research and data, the FDA found that the current standards for adding supplements to foods or beverages aren’t sufficient for cannabinoids such as CBD, Reuters reported.

“We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” FDA Principal Deputy Commissioner Janet Woodcock said.

The news reinforces a situation that’s long been apparent for those in the CBD trade: Congress needs to take action before the potential of the market can be fully unleashed.

The issue has been a thorn in the side of hemp and CBD companies for years; the FDA ruled back in 2015 that CBD was not permitted to be used in foods or beverages as a supplement, and it has remained steadfast in that position ever since.

The agency has also been cracking down for years on CBD producers that make health benefit claims or other assertions about their product lines which can’t yet be backed up by solid science, or which have been marketed to kids. (Full Story)

In categories:CBD Medical
Next Post

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs  CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The…
Read
Previous Post

Too good to be brew! DMT - the potent psychedelic in Ayahuasca - treats depression after a SINGLE dose, cutting-edge clinical trial shows

DMT — the most potent psychedelic known to man —  treats people with severe depression after a single dose, a cutting-edge clinical trial suggests. Up to six in ten who received a single dose of DMT intravenously before therapy were declared depression-free…
Read
Random Post

Schumer Says Congress Is ‘Very Close’ To Passing Marijuana Banking And Expungements Bill After Work With ‘A Bunch Of Republicans’

Senate Majority Leader Chuck Schumer (D-NY) says Congress is getting “very close” to introducing and passing a marijuana bill with provisions covering banking access for legal businesses and expungements of past convictions, citing progress he’s made in discussions with a…
Read
Random Post

Texas Activists Turn In Signatures To Put Marijuana Decriminalization Back In Voters’ Hands After City Council Repeal

Texas activists have turned in what they say are enough signatures to place a measure on the Harker Heights ballot to reverse a City Council move that repealed a voter-approved marijuana decriminalization initiative. Ground Game Texas, which was behind a…
Read
Random Post

Psychedelics, Chat GPT, Chopra: At SXSW, Silicon Valley gets in its feelings

Analysis The vibes are different. Deepak Chopra is advocating for psychedelic therapy as a gateway to higher collective consciousness. SXSW patrons are invited to take off their shoes and meditate in a dark room while a harpist plays along to music written by…
Read
Random Post

If Japan Legalizes Medical Marijuana, What Does That Mean for the Rest of Asia?

Thursday's recommendation by a health ministry panel to allow cannabis-based medications might herald a historic shift in the nation's strict drug laws. Since the group advocated for tighter laws against non-medical marijuana use, the modification may have no bearing on Japan's…
Read